↓ Skip to main content

PLOS

First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy

Overview of attention for article published in PLOS ONE, September 2011
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
3 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
58 Mendeley
Title
First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy
Published in
PLOS ONE, September 2011
DOI 10.1371/journal.pone.0023243
Pubmed ID
Authors

Peter A. Anton, Terry Saunders, Julie Elliott, Elena Khanukhova, Robert Dennis, Amy Adler, Galen Cortina, Karen Tanner, John Boscardin, William G. Cumberland, Ying Zhou, Ana Ventuneac, Alex Carballo-Diéguez, Lorna Rabe, Timothy McCormick, Henry Gabelnick, Christine Mauck, Ian McGowan

Abstract

Successful control of the HIV/AIDS pandemic requires reduction of HIV-1 transmission at sexually-exposed mucosae. No prevention studies of the higher-risk rectal compartment exist. We report the first-in-field Phase 1 trial of a rectally-applied, vaginally-formulated microbicide gel with the RT-inhibitor UC781 measuring clinical and mucosal safety, acceptability and plasma drug levels. A first-in-Phase 1 assessment of preliminary pharmacodynamics was included by measuring changes in ex vivo HIV-1 suppression in rectal biopsy tissue after exposure to product in vivo.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Portugal 1 2%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 22%
Professor > Associate Professor 8 14%
Student > Master 8 14%
Student > Ph. D. Student 5 9%
Student > Bachelor 4 7%
Other 12 21%
Unknown 8 14%
Readers by discipline Count As %
Medicine and Dentistry 16 28%
Agricultural and Biological Sciences 9 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Social Sciences 4 7%
Immunology and Microbiology 3 5%
Other 10 17%
Unknown 11 19%